| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |